Patents by Inventor Shawn Anthony Kucera

Shawn Anthony Kucera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS
    Publication number: 20220340574
    Abstract: The preparation and properties of crystalline polymorphs and solvates of 1-benzyl-8-methyl-1,4,8-triazaspiro-[4.5]-decan-2-one free base and of the mono-and dihydrochloride salts and solvates thereof are disclosed, as is an amorphous polymorph of the dihydrochloride. A pharmaceutical composition containing one or more polymorphs and a method of using that composition are also disclosed.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 27, 2022
    Applicant: Cassava Sciences, Inc.
    Inventors: Michael Zamloot, Lindsay Burns Barbier, Shawn Anthony Kucera
  • Solid polymorphs of a FLNA-binding compound and its hydrochloride salts
    Patent number: 11370791
    Abstract: The preparation and properties of crystalline polymorphs and solvates of 1-benzyl-8-methyl-1,4,8-triazaspiro-[4.5]-decan-2-one free base and of the mono- and dihydrochloride salts and solvates thereof are disclosed, as is an amorphous polymorph of the dihydrochloride. A pharmaceutical composition containing one or more polymorphs and a method of using that composition are also disclosed.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: June 28, 2022
    Assignee: CASSAVA SCIENCES, INC.
    Inventors: Michael Zamloot, Lindsay Burns Barbier, Shawn Anthony Kucera
  • SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS
    Publication number: 20200270250
    Abstract: The preparation and properties of crystalline polymorphs and solvates of 1-benzyl-8-methyl-1,4,8-triazaspiro-[4.5]-decan-2-one free base and of the mono- and dihydrochloride salts and solvates thereof are disclosed, as is an amorphous polymorph of the dihydrochloride. A pharmaceutical composition containing one or more polymorphs and a method of using that composition are also disclosed.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Inventors: Michael Zamloot, Lindsay Burns Barbier, Shawn Anthony Kucera